Is Lifecore Biomedical Inc. (LFCR) overvalued? · $207.1M cap
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This page asks whether Lifecore Biomedical Inc. (LFCR) looks expensive on cached numbers — not a short thesis.
No cached income statement for LFCR, so there is no earnings base to call rich or cheap.
LFCR currently screens at market cap $207.1M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next LFCR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the LFCR stock page for the full model, not this heading.
Not investment advice.